CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders of $1.95 million for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Shareholders' Equity
us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2025-09-27 was $1.95M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2024-06-29 was $1.94M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2024-03-30 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2023-09-30 was $1.65M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2025 was $1.95M, a 0.72% increase from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2024 was $1.94M, a 17.81% increase from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2023 was $1.65M, a 5.41% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2022 was $1.74M, a 7.75% decline from fiscal 2021.
| Period end | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 3 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 6 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 9 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 12 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-27 | $1.95M 10-K · filed 2026-02-18 | ||||
| 2025-09-27 | $1.95M 10-Q · filed 2025-11-05 | ||||
| 2024-12-28 | $1.94M 10-K · filed 2026-02-18 | ||||
| 2024-06-29 | $1.94M 10-Q · filed 2025-11-05 | $1.94M derived: sum of 2 quarters · filed 2025-11-05 | |||
| 2024-03-30 | $0.00 10-Q · filed 2025-05-07 | ||||
| 2023-12-30 | $1.65M 10-K · filed 2026-02-18 | ||||
| 2023-09-30 | $1.65M 10-Q · filed 2024-11-06 | ||||
| 2022-12-31 | -$1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $1.74M 10-K · filed 2025-02-19 | |||
| 2022-09-24 | $3.52M 10-Q · filed 2022-11-02 | ||||
| 2021-12-25 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $1.89M 10-K · filed 2024-02-14 | |||
| 2021-09-25 | $0.00 10-Q · filed 2022-11-02 | ||||
| 2020-12-26 | $1.53M 10-K · filed 2023-02-22 | ||||
| 2019-12-28 | $1.29M 10-K · filed 2022-02-16 | ||||
| 2018-12-29 | $1.43M 10-K · filed 2021-02-17 | ||||
| 2017-12-30 | $1.21M 10-K · filed 2020-02-11 | ||||
| 2016-12-31 | $2.90M 10-K · filed 2019-02-13 | ||||
| 2010-12-25 | -$540.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$540.00K derived: sum of 2 quarters · filed 2013-02-27 | -$270.00K 10-K · filed 2013-02-27 | $270.00K 10-K · filed 2011-02-23 | |
| 2010-09-25 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $270.00K 10-Q · filed 2011-11-02 | |||
| 2010-06-26 | $270.00K 10-Q · filed 2011-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |